TransVoyant Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.92M
- Investors
-
3
TransVoyant General Information
Description
Developer of a data analytics platform designed to provide live and predictive insights from real-time data. The company's offerings include collecting data from devices such as radar, sensors, satellites, smartphones and meters and giving predictive insights, enabling organizations and governments to anticipate and avoid threats and disruptions resulting from weather, port congestion, natural disasters, supplier failure, road construction and labor strikes.
Contact Information
Website
www.transvoyant.comCorporate Office
- 5845 Richmond Highway
- Alexandria, VA 22303
- United States
Corporate Office
- 5845 Richmond Highway
- Alexandria, VA 22303
- United States
TransVoyant Timeline
TransVoyant Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC | 01-Mar-2024 | $8.92M | Completed | Generating Revenue | ||
7. Later Stage VC (Series C) | 08-Dec-2022 | Completed | Generating Revenue | |||
6. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
5. Later Stage VC | 15-Aug-2019 | Completed | Generating Revenue | |||
4. Later Stage VC (Series B3) | 18-Mar-2019 | Completed | Generating Revenue | |||
3. Debt - General | 19-Feb-2019 | Completed | Generating Revenue | |||
2. Later Stage VC (Series B3) | 27-Jun-2017 | $500K | $3.62M | Completed | Generating Revenue | |
1. Later Stage VC (Series B2) | 01-Jan-2016 | $3.12M | $3.12M | Completed | Generating Revenue |
TransVoyant Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B4 | ||||||||
Series B3 | ||||||||
Series B2 | ||||||||
Series B1 | ||||||||
Series B | 217,400 | $0.000010 | $3.68 | $3.68 | 1x | $3.68 | 3.02% | |
Series A | 1,428,571 | $0.000010 | $3.01 | $3.01 | 1x | $3.01 | 19.84% |
TransVoyant Comparisons
Industry
Financing
Details
TransVoyant Competitors (44)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
KloudFuse | Venture Capital-Backed | Cupertino, CA | ||||
Databricks | Venture Capital-Backed | San Francisco, CA | ||||
Sumo Logic | Private Equity-Backed | Redwood City, CA | ||||
Datadog | Formerly VC-backed | New York, NY | ||||
Trademo | Venture Capital-Backed | Palo Alto, CA |
TransVoyant Patents
TransVoyant Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3485288-A4 | System and method for tracking assets | Inactive | 18-Jul-2016 | ||
EP-3485288-A1 | System and method for tracking assets | Inactive | 18-Jul-2016 | ||
US-20210065097-A1 | System and method for tracking assets | Active | 18-Jul-2016 | ||
US-10860965-B2 | System and method for tracking assets | Active | 18-Jul-2016 | ||
US-11507911-B2 | System and method for tracking assets | Active | 18-Jul-2016 | G06Q10/08 |
TransVoyant Executive Team (13)
Name | Title | Board Seat |
---|---|---|
Dennis Groseclose | Co-Founder, President, Chief Executive Officer & Board Member | |
James Butera | Vice President, Customer Growth & Interim Chief Revenue Officer | |
Allison Fowler | Chief Product Officer | |
Timothy Fleischer | Co-Founder & Chairman | |
Gary Gonzalez | Vice President of Sales |
TransVoyant Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Dennis Groseclose | TransVoyant | Co-Founder, President, Chief Executive Officer & Board Member | |
Jeremy Sohn | Self | Board Member | |
Joseph Volpe III | Merck Global Health Innovation Fund | Board Member | |
Patrick McPherson | Self | Board Member | |
Timothy Fleischer | TransVoyant | Co-Founder & Chairman |
TransVoyant Signals
TransVoyant Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Merck Global Health Innovation Fund | Corporate Venture Capital | Minority | ||
P74 Ventures | Venture Capital | Minority | ||
In-Q-Tel | Not-For-Profit Venture Capital | Minority |
TransVoyant Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
ObjectFX | 27-Sep-2011 | Application Software |
TransVoyant FAQs
-
When was TransVoyant founded?
TransVoyant was founded in 2011.
-
Who is the founder of TransVoyant?
Dennis Groseclose and Timothy Fleischer are the founders of TransVoyant.
-
Who is the CEO of TransVoyant?
Dennis Groseclose is the CEO of TransVoyant.
-
Where is TransVoyant headquartered?
TransVoyant is headquartered in Alexandria, VA.
-
What is the size of TransVoyant?
TransVoyant has 33 total employees.
-
What industry is TransVoyant in?
TransVoyant’s primary industry is Media and Information Services (B2B).
-
Is TransVoyant a private or public company?
TransVoyant is a Private company.
-
What is TransVoyant’s current revenue?
The current revenue for TransVoyant is
. -
How much funding has TransVoyant raised over time?
TransVoyant has raised $9.1M.
-
Who are TransVoyant’s investors?
Merck Global Health Innovation Fund, P74 Ventures, and In-Q-Tel have invested in TransVoyant.
-
Who are TransVoyant’s competitors?
KloudFuse, Databricks, Sumo Logic, Datadog, and Trademo are some of the 44 competitors of TransVoyant.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »